11:30 EDT Iterum Therapeutics (ITRM) PLC trading resumes
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITRM:
- Iterum Therapeutics announces FDA approval of Orlynvah
- Iterum Therapeutics jumps 20% to $1.41 after FDA posts approval
- Iterum Therapeutics PLC trading halted, news pending
- Iterum provides update on FDA advisory committee discussion on oral sulopenem
- Biotech Alert: Searches spiking for these stocks today